Role of ICAM-1 in the Adherence of Human Neutrophils to Human Endothelial Cells In Vitro
The adherence of human neutrophils to endothelial cells and protein-coated foreign surfaces in vitro is significantly increased by chemotactic stimulation or exposure of the cells to secretagogues (1–7). The CD11b/ CD18 (Mac-1) heterodimer on the neutrophil’s surface appears to play a role as shown by the inhibitory effect of some monoclonal antibodies reactive with either CD1 lb or CD18 (4,5,8,9). Stimulation of endothelial cells with bacterial endotoxin (LPS) (4,10,11), interleukin-1 (IL-1) (4,12,13), tumor necrosis factor-α (TNF-α) (4,5,12–14), or lymphotoxin (LT) (13) increases the adherence of unstimulated neutrophils. In contrast to the rapid response following chemotactic stimulation of neutrophils, this increase is not evident until > 1 hour after stimulation, and protein synthesis is required. The specific CD11/CD18 heterodimers important to this cytokine-induced adherence have not been defined. We have recently obtained evidence that the CD18-dependent adherence of human neutrophils to cytokine-stimulated endothelial cells involves intercellular adherence molecule-1 (ICAM-1) expressed on the endothelial surface (7). In light of recent evidence that ICAM-1 (15,16) is a ligand for the CD11a/ CD18 (LFA-1) heterodimer (17,18), consideration was given to the possibility that LFA-1 contributes to the adherence of neutrophils to cytokine stimulated endothelial cells.
KeywordsWall Shear Stress Human Neutrophil Flow Chamber Transendothelial Migration Neutrophil Adherence
Unable to display preview. Download preview PDF.
- 11.Dunn CJ, Fleming WE: Increased adhesion of polymorphonuclear leukocytes to vascular endothelium by specific interaction of endogenous (interleukin-1) and exogenous (lipopolysaccharide) substances with endothelial cells “in vitro.” Eur J Rheum Inflam 7:80–86, 1984.Google Scholar
- 13.Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick Jr. DL, Gimbrone MA: Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 138:3319–3324, 1987.PubMedGoogle Scholar
- 14.Broudy VC, Harlan JM, Adamson JW: Disparate effects of tumor necrosis factor-a/cachectin and tumor necrosis factor-b/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells. J Immunol 138:4298–4302, 1987.PubMedGoogle Scholar
- 20.Lawrence MB, McIntire LV, Eskin SG, Smith CW: Involvement of CD18 in human neutrophil adhesion to endothelium under flow conditions. FASEB 2(5):A1237–5469a, 1988.Google Scholar
- 21.Furie MB, McHugh DD: Stimulation of neutrophil transendothelial migration by interleukin-1. J Cell Biol 105:276a (Abstract), 1987.Google Scholar
- 26.Anderson DC, Schmalstieg FC, Finegold MJ, Hughes BJ, Rothlein R, Miller LJ, Kohl S, Tosi MF, Jacobs RL, Waldrop TC, Goldman AS, Shearer WT, Springer TA: The severe and moderate phenotypes of heritable Mac-1, LFA-1, p150,95 deficiency: Their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infec Dis 152:668–689, 1985.CrossRefGoogle Scholar
- 28.Anderson DC, Schmalstieg FC, Kohl S, Arnaout MA, Hughes BJ, Tosi MF, Buffone GJ, Brinkley BR, Dickey WD, Abramson JS, Springer TA, Boxer LA, Hollers JM, Smith CW: Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): Common relationship to diminished cell adherence. J Clin Invest 74:536–551, 1984.PubMedCrossRefGoogle Scholar
- 36.Ross, GD, Thompson RA, Walport MJ, Springer TA, Watson JV, Ward RHR, Lida J, Newman SL, Harrison RA, Lachmann PJ: Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1. Blood 66:882–890, 1985.PubMedGoogle Scholar
- 37.Wright SD, Jong MTC, Levin SM. 1988. CR3 expresses two binding sites, one for RGD-peptide, and one for bacterial LPS. FASEB 2:a1237 (Abstract), 1988.Google Scholar
- 38.Lo SK, Wright SD: CR3 mediates binding or PMN to endothelial cells (EC) via its RGD binding, not the LPS binding site. FASEB 2:A1236 (Abstract), 1988.Google Scholar